the kinetic disposition of nicorandil , n- [ 2- ( nitroxy ) ethyl ] -3- pyridinecarboxamide ( 1 ) , and its main metabolic product , n- [ 2- ( hydroxy ) -ethyl ] -3- pyridinecarboxamide ( ii ) , was studied after administering intravenous and oral doses ( 2.5 mg/kg ) of nicorandil to the same beagle dogs .
C0028027
3
C0068700
nicorandil